Narayana Hrudayalaya consolidated revenue jumps 44% on UK acquisition
Standalone net profit rose 16.7% as the company closed its first full year following the November 2025 entry into the UK market.
— 1 earlier story on Narayana Hrudayalaya Ltd. →What's new
- Consolidated revenue rose 44% YoY to ₹78,960 million.
- Standalone net profit hit ₹5,031 million, a 16.7% increase.
- Board approved a final dividend of ₹4.50 per share and debt issuance up to ₹1,500 crores.
Why it matters
The consolidated top-line surge reflects the integration of Practice Plus Group, Narayana’s major UK expansion. Routine dividends and debt approvals signal stability, leaving the focus on the company's ability to maintain standalone margins while managing its new international footprint.
What we're watching
- Margin progression as the UK hospitals are fully integrated into the consolidated P&L.
- Usage of the newly approved ₹1,500 crore debt headroom.
- Standalone core growth trends in the coming fiscal year.
The full read
Narayana Hrudayalaya closed FY26 with a 44% surge in consolidated revenue to ₹78,960 million. This sharp jump is the result of the Practice Plus Group acquisition completed in November 2025. Standalone performance was more measured, with revenue climbing 10.7% to ₹39,751 million and net profit growing 16.7% to ₹5,031 million. The board kept the final dividend unchanged at ₹4.50 per share and authorised the company to raise up to ₹1,500 crores in debt. These results contain no surprises. The numbers align with broad expectations, confirming that the company's recent international expansion is the primary driver of its current scale. What changes from here is the company's ability to manage its new debt headroom and sustain standalone profitability while balancing its growing UK-based operations.